Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 2.28 M4.9 M — Research & development 226.57 K221.24 K — Operating income -1.84 M-4.9 M — Non-Operating Income, Total -865.17 K-4.93 M — Interest expense, net of interest capitalized 870.72 K2.23 M — Non-Operating Income, excl. Interest Expenses -1.74 M-7.16 M — Unusual income/expense 5 275— — Pretax income -3.58 M-12.06 M — Equity in earnings 1 711140 — Taxes 22.63 K78.46 K — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -2.73 M-9.91 M — Discontinued operations —— — Net income -2.73 M-9.91 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -2.73 M-9.91 M — Basic earnings per share (Basic EPS) -0.09-0.39 — Diluted earnings per share (Diluted EPS) -0.09-0.39 — Average basic shares outstanding 30.84 M23.05 M — Diluted shares outstanding 30.84 M23.05 M — EBITDA -1.54 M-2.42 M — EBIT -1.84 M-4.9 M — Cost of revenue 674.4 K1.1 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 301.31 K2.48 M —